UGent presented a paper on predictive models for mortality and hospitalization and predictive factors for quality of life patients with congestive heart failure. This paper was based on two systematic reviews conducted for the HeartMan project.
The HeartMan project held a technical meeting in Madrid on 6th and 7th March 2017 in Atos premises. During two days the HeartMan prototyping team discussed the use cases and scenarios in order to finalize the Graphical User Interface sketches.
The HeartMan project held a consortium meeting in Ghent on 24th January 2017. During two days, several issues were discussed, related to Human Centered Design, wristbands and other devices, physical and psychological monitoring methods, medical psychological and combined Decision Support Systems and its predictive models, trial protocol and needed updates, backend platform and web interface, integration, design input document and how to proceed to satisfy regulatory requirements.
UGent presented a paper on predictive factors for quality of life in patients with congestive heart failure. This paper was based on a systematic review conducted for the HeartMan project.
UGent presented a paper on predictive factors for quality of life in patients with congestive heart failure. This paper was based on a systematic review conducted for the HeartMan project.
Our partners KUL & UGent met with Belgian caregivers from the participating hospitals to discuss the personalized advice that will be given to the users and to obtain feedback on the functionalities of the HeartMan system.
A new HeartMan Project plenary meeting took place in Messina, Sicily, and it was very productive. Architecture was completed and the development is progressing quite well.
UGent & UOR met to discuss how to implement the medical guidelines and preexisting predictive models in the decision support system.
HeartMan team has been screening almost 10.000 articles for mortality, hospitalisation and quality of life. This work is being performed in the context of WP2.
HeartMan has just received approval from the ethical board to proceed with a first study into CHF patients' user needs and experiences!
This project has received funding from the European Union’s Horizon 2020 research and innovation programme under grant agreement no 689660.